The Radiation Oncology Registry and Biosample Repository

NCT ID: NCT01577251

Last Updated: 2025-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

8000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
* Able to sign consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abramson Cancer Center at Penn Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jay Dorsey, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virtua Samson Cancer Center

Moorestown, New Jersey, United States

Site Status NOT_YET_RECRUITING

Virtua Health & Wellness Center

Voorhees Township, New Jersey, United States

Site Status RECRUITING

Lancaster General Hospital

Lancaster, Pennsylvania, United States

Site Status RECRUITING

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Project Manager

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Susan VanLoon, RN, ODS-C, CCRP

Role: primary

856-247-7382 ext. 77382

Susan VanLoon, RN, ODS-C, CCRP

Role: primary

856-247-7382 ext. 77382

Alyson Eckert, RN

Role: primary

717-544-0511

Project Manager

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UPCC 11908

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gut Microbiota And Radiotherapy
NCT02559349 COMPLETED
DIBH Proton Planning
NCT01386697 COMPLETED